MORPHINE-3-GLUCURONIDE - A POTENT ANTAGONIST OF MORPHINE ANALGESIA

被引:277
作者
SMITH, MT [1 ]
WATT, JA [1 ]
CRAMOND, T [1 ]
机构
[1] UNIV QUEENS LAND,DIV ANAESTHET,ST LUCIA,QLD 4072,AUSTRALIA
关键词
D O I
10.1016/0024-3205(90)90619-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In this study, morphine-3-glucuronide (M3G), the major plasma and urinary metabolite of morphine, was shown to be a potent antagonist of morphine analgesia when administered to rats by the intra-cerebroventricular (i.c.v.) route. The antagonism of morphine analgesia was observed irrespective of whether i.c.v. M3G (2.5 or 3.0μg) was administered 15 mins prior to or 15 mins after i.c.v. morphine (20μg). When M3G (10mg) was administered intraperitoneally (i.p.) to rats 30-40 mins prior to morphine (1.5mg i.p.), the analgesic response was significantly reduced compared to administration of morphine (1.5mg i.p.) alone. It was further demonstrated that i.c.v. M3G (2.0μg) antagonized the analgesic effects of subsequently administered i.c.v. morphine-6-glucuronide (0.25μg). © 1990.
引用
收藏
页码:579 / 585
页数:7
相关论文
共 11 条
[1]   DETERMINATION OF MICROSOMAL UDP-GLUCURONYLTRANSFERASE IN NEEDLE-BIOPSY SPECIMENS OF HUMAN LIVER [J].
BOCK, KW ;
BRUNNER, G ;
HOENSCH, H ;
HUBER, E ;
JOSTING, D .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 14 (05) :367-373
[2]  
BRADY LS, 1982, J PHARMACOL EXP THER, V222, P190
[3]  
IWANATO K, 1977, J PHARMACOL EXP THER, V200, P236
[4]   MORPHINE DERIVATIVES WITH DIMINISHED OPIATE RECEPTOR POTENCY SHOW ENHANCED CENTRAL EXCITATORY ACTIVITY [J].
LABELLA, FS ;
PINSKY, C ;
HAVLICEK, V .
BRAIN RESEARCH, 1979, 174 (02) :263-271
[5]   ENHANCED BINDING OF MORPHINE AND NALORPHINE TO OPIOID DELTA RECEPTOR BY GLUCURONATE AND SULFATE CONJUGATIONS AT THE 6-POSITION [J].
OGURI, K ;
YAMADAMORI, I ;
SHIGEZANE, J ;
HIRANO, T ;
YOSHIMURA, H .
LIFE SCIENCES, 1987, 41 (12) :1457-1464
[6]   MORPHINE-6-GLUCURONIDE, A POTENT MU AGONIST [J].
PASTERNAK, GW ;
BODNAR, RJ ;
CLARK, JA ;
INTURRISI, CE .
LIFE SCIENCES, 1987, 41 (26) :2845-2849
[7]   MORPHINE-METABOLISM IN CANCER-PATIENTS ON INCREASING ORAL DOSES - NO EVIDENCE FOR AUTOINDUCTION OR DOSE-DEPENDENCE [J].
SAWE, J ;
SVENSSON, JO ;
RANE, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (01) :85-93
[8]   INTRATHECAL HIGH-DOSE MORPHINE PRODUCES HYPERALGESIA IN THE RAT [J].
WOOLF, CJ .
BRAIN RESEARCH, 1981, 209 (02) :491-495
[9]   HIGH-DOSES OF SPINAL MORPHINE PRODUCE A NONOPIATE RECEPTOR-MEDIATED HYPERESTHESIA - CLINICAL AND THEORETIC IMPLICATIONS [J].
YAKSH, TL ;
HARTY, GJ ;
ONOFRIO, BM .
ANESTHESIOLOGY, 1986, 64 (05) :590-597
[10]  
YAKSH TL, 1988, J PHARMACOL EXP THER, V244, P501